Post-ATU Study of Nivolumab
NCT03325257
·
clinicaltrials.gov ↗
COMPLETED
Status
350
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
OTHER:
Routine care
Sponsor
Nantes University Hospital
Collaborators
[object Object]